SCHEMBL22216339

SCHEMBL22216339

CCNC(=O)c1cnn(C/C(=C/F)CN)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 13/20 0.41
LMNA P02545 3/20 0.40
HPGD P15428 2/20 0.40
KLK1 P06870 3/20 0.38
MAPT P10636 1/20 0.37
CYP2C19 P33261 1/20 0.37
GFER P55789 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
PRKAB2 O43741 1/20 0.35
ABL1 P00519 1/20 0.35
CSF1R P07333 1/20 0.35
LYN P07948 1/20 0.35
PRKAG1 P54619 1/20 0.35
SIK1 P57059 1/20 0.35
PRKAA1 Q13131 1/20 0.35
SIK2 Q9H0K1 1/20 0.35
SIK3 Q9Y2K2 1/20 0.35
PDK2 Q15119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22216455 0.90 LMNA (0.42) KLKB1LMNAHPGDKLK1MAPT
SCHEMBL22216335 0.87 KLKB1 (0.37) KLKB1LMNAHPGDKLK1MAPT
SCHEMBL23907287 0.85 LMNA (0.39) KLKB1LMNAHPGDMAPTCYP2C19
SCHEMBL23907289 0.85 LMNA (0.39) KLKB1LMNAHPGDMAPTCYP2C19
SCHEMBL28426244 0.85 LMNA (0.37) KLKB1LMNAHPGDKLK1MAPT
SCHEMBL28426245 0.85 LMNA (0.37) KLKB1LMNAHPGDKLK1MAPT
SCHEMBL22216397 0.84 AOC3 (0.51) KLKB1LMNAHPGDKLK1MAPT
SCHEMBL23920660 0.83 L3MBTL1 (0.38) KLKB1L3MBTL1
SCHEMBL22206967 0.82 GRM2 (0.38) HPGDL3MBTL1
SCHEMBL22206966 0.82 GRM2 (0.38) HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111434662-B Haloallylamine compound and application thereof 药捷安康(南京)科技股份有限公司 2023-01-10 CN disclosed
EP-3892621-A1 HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF Nanjing Transthera Biosciences Co., Ltd. (CN) 2021-10-13 EP disclosed
WO-2020143763-A1 HALOALLYLAMINE COMPOUNDS AND APPLICATION THEREOF 南京药捷安康生物科技有限公司 2020-07-16 WO disclosed